[HTML][HTML] Restoration of asymmetric dimethylarginine–nitric oxide balance to prevent the development of hypertension

YL Tain, LT Huang - International Journal of Molecular Sciences, 2014 - mdpi.com
Despite the use of extensive antihypertensive therapy in patients with hypertension, little
attention has been paid to early identification and intervention of individuals at risk for …

[HTML][HTML] Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control

CP Hsu, PF Hsu, MY Chung, SJ Lin, TM Lu - Cardiovascular diabetology, 2014 - Springer
Background and aims Elevated plasma asymmetric dimethylarginine (ADMA) levels have
been observed in patients with insulin resistance and diabetes, and have been reported to …

[HTML][HTML] Effects of folic acid supplementation on serum homocysteine levels, lipid profiles, and vascular parameters in post-menopausal Korean women with type 2 …

A Vijayakumar, E Kim, H Kim, YJ Choi… - Nutrition Research …, 2017 - synapse.koreamed.org
BACKGROUND/OBJECTIVES Complications of diabetes, such as cardiovascular disease,
are associated with increased mortality among type 2 diabetes mellitus patients …

[HTML][HTML] Normal weight diabetic patients versus obese diabetics: relation of overall and abdominal adiposity to vascular health

A Lukich, D Gavish, M Shargorodsky - Cardiovascular Diabetology, 2014 - Springer
Objective The present study investigated the impact of overall obesity defined by BMI and
abdominal obesity defined by WC on vascular atherosclerotic changes in obese and normal …

Multidisciplinary treatment of the metabolic syndrome lowers blood pressure variability independent of blood pressure control

Y Marcus, E Segev, G Shefer, J Sack… - The Journal of …, 2016 - Wiley Online Library
Blood pressure (BP) variability (BPV) contributes to target organ damage independent of BP.
The authors examined the effect of a 1‐year multidisciplinary intervention on BPV in patients …

LncRNA DANCR deficiency promotes high glucose-induced endothelial to mesenchymal transition in cardiac microvascular cells via the FoxO1/DDAH1/ADMA …

M Wu, T Li, G Li, B Niu, T Wu, L Yan, S Wang… - European Journal of …, 2023 - Elsevier
Cardiac fibrosis is the main pathological basis of diabetic cardiomyopathy (DCM), and
endothelial-to-meschenymal transition (EndMT) is a key driver to cardiac fibrosis and plays …

ADMA (asymmetric dimethylarginine) and angiogenic potential in patients with type 2 diabetes and prediabetes

R Wieczór, AM Wieczór, A Kulwas… - … Biology and Medicine, 2021 - journals.sagepub.com
Asymmetric dimethylarginine is an endogenous competitive inhibitor of nitric oxide synthase
and marker of endothelial dysfunction, but the question remains as to whether asymmetric …

[HTML][HTML] Neck circumference and early stage atherosclerosis: the cardiometabolic risk in Chinese (CRC) study

J Liang, Y Wang, H Li, X Liu, Q Qiu, L Qi - Cardiovascular diabetology, 2014 - Springer
Background Neck circumference (NC) has been previously related to cardiometabolic risk
factors. In this study we examined the association between NC and early stage …

[HTML][HTML] Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study

A Surdacki, O Kruszelnicka, T Rakowski… - Cardiovascular …, 2013 - Springer
Background Endothelial dysfunction, largely dependent on impaired nitric oxide
bioavailability, has been reportedly associated with incident type 2 diabetes. Our aim was to …

[HTML][HTML] Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non …

O Kruszelnicka, A Surdacki, A Golay - Cardiovascular Diabetology, 2013 - Springer
Background Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthesis
inhibitor, and insulin resistance (IR) have been implicated in atherogenesis. Our aim was to …